The DOI matches its Crossref record.
Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS‐5 and delays cartilage degradation in murine osteoarthritis
Abstract
Objective: We have previously identified in articular cartilage an abundant pool of the heparin‐binding growth factor, fibroblast growth factor 2 (FGF‐2), which is bound to the pericellular matrix heparan sulfate proteoglycan, perlecan. This pool of FGF‐2 activates chondrocytes upon tissue loading and is released following mechanical injury. In vitro, FGF‐2 suppresses interleukin‐1–driven aggrecanase activity in human cartilage explants, suggesting a chondroprotective role in vivo. We undertook this study to investigate the in vivo role of FGF‐2 in murine cartilage. Methods: Basal characteristics of the articular cartilage of Fgf2 −/− and Fgf2 +/+ mice were determined by histomorphometry, nanoindentation, and quantitative reverse transcriptase–polymerase chain reaction. The articular cartilage was graded histologically in aged mice as well as in mice in which osteoarthritis (OA) had been induced by surgical destabilization of the medial meniscus. RNA was extracted from the joints of Fgf2 −/− and Fgf2 +/+ mice following surgery and quantitatively assessed for key regulatory molecules. The effect of subcutaneous administration of recombinant FGF‐2 on OA progression was assessed in Fgf2 −/− mice. Results: Fgf2 −/− mice were morphologically indistinguishable from wild‐type (WT) animals up to age 12 weeks; the cartilage thickness and proteoglycan staining were equivalent, as was the mechanical integrity of the matrix. However, Fgf2 −/− mice exhibited accelerated spontaneous and surgically induced OA. Surgically induced OA in Fgf2 −/− mice was suppressed to levels in WT mice by subcutaneous administration of recombinant FGF‐2. Increased disease in Fgf2 −/− mice was associated with increased expression of messenger RNA of Adamts5 , the key murine aggrecanase. Conclusion: These data identify FGF‐2 as a novel endogenous chondroprotective agent in articular cartilage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
FGF/FGFR signaling in health and disease
Xie, Y., Su, N., Yang, J., Tan, Q., Huang, S., Jin, M., Ni, Z., Zhang, B., Zhang, D., Luo, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00222-7 · Cited by 904
Proteases involved in cartilage matrix degradation in osteoarthritis
Troeberg, L., & Nagase, H. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2011.06.020 · Cited by 579
Osteoarthritis Pathogenesis: A Review of Molecular Mechanisms
Xia, B., Chen, D., Zhang, J., Hu, S., Jin, H., & Tong, P. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9917-9 · Cited by 543
Zhu, G., Zhang, T., Chen, M., Yao, K., Huang, X., Zhang, B., Li, Y., Liu, J., Wang, Y., & Zhao, Z. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.03.043 · Cited by 494
Goldring, M. B. (2012) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x12448454 · Cited by 444
Metadata
- Authors
- Chia, S., Sawaji, Y., Burleigh, A., McLean, C., Inglis, J., Saklatvala, J., & Vincent, T.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2009-06-29
- Volume
- 60
- Issue
- 7
- Pages
- 2019-2027
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W1983227824
- Cited by
- 201
- References
- 0
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS‐5 and delays cartilage degradation in murine osteoarthritis. https://app.cochat.ai/papers/10.1002/art.24654
- The paper
- Chia, S., Sawaji, Y., Burleigh, A., McLean, C., Inglis, J., Saklatvala, J., & Vincent, T. (2009). Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS‐5 and delays cartilage degradation in murine osteoarthritis. Arthritis & Rheumatism. https://doi.org/10.1002/art.24654
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.